Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant

Akinbami Adenugba1, Matthias Hornung1, Kilian Weigand2

  • 1Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

Transplantation
|February 15, 2021
PubMed
Abstract